434
Views
3
CrossRef citations to date
0
Altmetric
Articles/Brief Reports

Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection

, , , , , & show all
Pages 455-461 | Accepted 31 Dec 2020, Published online: 09 Mar 2021

References

  • Leonard MH. Trochanteric syndrome; calcareous and noncalcareous tendonitis and bursitis about the trochanter major. J Am Med Assoc 1958;168:175–7.
  • Lievense A, Bierma-Zeinstra S, Schouten B, Bohnen A, Verhaar J, Koes B. Prognosis of trochanteric pain in primary care. Br J Gen Pract J R Coll Gen Pract 2005;55:199–204.
  • Segal NA, Felson DT, Torner JC, Zhu Y, Curtis JR, Niu J, et al. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil 2007;88:988–92.
  • Collée G, Dijkmans BA, Vandenbroucke JP, Rozing PM, Cats A. A clinical epidemiological study in low back pain. Description of two clinical syndromes. Br J Rheumatol 1990;29:354–7.
  • Fearon AM, Cook JL, Scarvell JM, Neeman T, Cormick W, Smith PN. Greater trochanteric pain syndrome negatively affects work, physical activity and quality of life: a case control study. J Arthroplasty 2014;29:383–6.
  • Seidman AJ, Varacallo M. Trochanteric Bursitis StatPearls Publishing; 2019. (http://www.ncbi.nlm.nih.gov/books/NBK538503/). Accessed 8 January 2021.
  • Fearon A, Stephens S, Cook J, Smith P, Neeman T, Cormick W, et al. The relationship of femoral neck shaft angle and adiposity to greater trochanteric pain syndrome in women. A case control morphology and anthropometric study. Br J Sports Med 2012;46:888–92.
  • Tan LA, Benkli B, Tuchman A, Li XJ, Desai NN, Bottiglieri TS, et al. High prevalence of greater trochanteric pain syndrome among patients presenting to spine clinic for evaluation of degenerative lumbar pathologies. J Clin Neurosci 2018;53:89–91.
  • Williams BS, Cohen SP. Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg 2009;108:1662–70.
  • Schapira D, Nahir M, Scharf Y. Trochanteric bursitis: a common clinical problem. Arch Phys Med Rehabil 1986;67:815–17.
  • Fearon AM, Scarvell JM, Neeman T, Cook JL, Cormick W, Smith PN. Greater trochanteric pain syndrome: defining the clinical syndrome. Br J Sports Med 2013;47:649–53.
  • Grimaldi A, Mellor R, Nicolson P, Hodges P, Bennell K, Vicenzino B. Utility of clinical tests to diagnose MRI-confirmed gluteal tendinopathy in patients presenting with lateral hip pain. Br J Sports Med 2017;51:519–24.
  • Lequesne M, Mathieu P, Vuillemin-Bodaghi V, Bard H, Djian P. Gluteal tendinopathy in refractory greater trochanter pain syndrome: diagnostic value of two clinical tests. Arthritis Rheum 2008;59:241–6.
  • Ganderton C, Semciw A, Cook J, Pizzari T. Demystifying the clinical diagnosis of greater trochanteric pain syndrome in women. J Womens Health (Larchmt) 2017;26:633–43.
  • Bird PA, Oakley SP, Shnier R, Kirkham BW. Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndrome. Arthritis Rheum 2001;44:2138–45.
  • Shbeeb MI, O’Duffy JD, Michet CJ, O’Fallon WM, Matteson EL. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol 1996;23:2104–6.
  • Brinks A, van Rijn RM, Willemsen SP, Bohnen AM, Verhaar JAN, Koes BW, et al. Corticosteroid injections for greater trochanteric pain syndrome: a randomized controlled trial in primary care. Ann Fam Med 2011;9:226–34.
  • Brennan KL, Allen BC, Maldonado YM. Dry needling versus cortisone injection in the treatment of greater trochanteric pain syndrome: a noninferiority randomized clinical trial. J Orthop Sports Phys Ther 2017;47:232–9.
  • Estrela GQ, Furtado R, Natour J, Narimatsu S, Rosenfeld A. Blinded vs ultrasound-guided corticosteroid injections for the treatment of the greater trochanteric pain syndrome (SDPT): a randomized controlled trial. (Abstract THU03529). Ann Rheum Dis 2014;73:304.
  • Poulsen RC, Watts AC, Murphy RJ, Snelling SJ, Carr AJ, Hulley PA. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Ann Rheum Dis 2014;73:1405–13.
  • Dean BJF, Lostis E, Oakley T, Rombach I, Morrey ME, Carr AJ. The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum 2014;43:570–6.
  • Brinks A, Koes BW, Volkers ACW, Verhaar JAN, Bierma-Zeinstra SMA. Adverse effects of extra-articular corticosteroid injections: a systematic review. BMC Musculoskelet Disord 2010;11:206.
  • Nissen MJ, Brulhart L, Faundez A, Finckh A, Courvoisier DS, Genevay S. Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial. Clin Rheumatol 2019;38:647–55.
  • Fairbank JC, Couper J, Davies JB, O’Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy 1980;66:271–3.
  • Baron G, Tubach F, Ravaud P, Logeart I, Dougados M. Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis. Arthritis Rheum 2007;57:633–8.
  • Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004;8:283–91.
  • Dar G, Hicks GE. The immediate effect of dry needling on multifidus muscles’ function in healthy individuals. J Back Musculoskelet Rehabil 2016;29:273–8.
  • Bannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials. Ann Intern Med 2015;163:365–72.
  • Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716–23.
  • Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009;63:533–43.
  • Sevel LS, Craggs JG, Price DD, Staud R, Robinson ME. placebo analgesia enhances descending pain-related effective connectivity: a dynamic causal modeling study of endogenous pain modulation. J Pain 2015;16:760–8.
  • Stein N, Sprenger C, Scholz J, Wiech K, Bingel U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain 2012;153:2210–17.
  • De Maeseneer M, Gosselin R, De Ridder F, Shahabpour M, Vanderdood K. MR imaging changes in the trochanteric area of asymptomatic individuals: a potential for misdiagnosis of pain in the trochanteric region. Eur J Radiol 2009;72:480–2.
  • Barratt PA, Brookes N, Newson A. Conservative treatments for greater trochanteric pain syndrome: a systematic review. Br J Sports Med 2017;51:97–104.
  • Dean BJF, Gettings P, Dakin SG, Carr AJ. Are inflammatory cells increased in painful human tendinopathy? A systematic review. Br J Sports Med 2016;50:216–20.
  • Fearon AM, Twin J, Dahlstrom JE, Cook JL, Cormick W, Smith PN, et al. Increased substance P expression in the trochanteric bursa of patients with greater trochanteric pain syndrome. Rheumatol Int 2014;34:1441–8.
  • Bolton WS, Kidanu D, Dube B, Grainger AJ, Rowbotham E, Robinson P. Do ultrasound guided trochanteric bursa injections of corticosteroid for greater trochanteric pain syndrome provide sustained benefit and are imaging features associated with treatment response? Clin Radiol 2018;73:505.e9-505.e15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.